Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,091 recruiting studies in this area right now.
By phase
- Not applicable4,197
- Phase 2597
- Phase 1409
- Phase 3325
- Phase 4251
- Phase 1/Phase 2246
- Phase 2/Phase 366
Top conditions
- Ovarian Cancer337
- Cervical Cancer223
- Endometrial Cancer205
- Bladder Cancer187
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy128
- Chronic Kidney Diseases122
- Breast Cancer110
- Chronic Kidney Disease107
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer77
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Kidney Cancer59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- AstraZeneca38
- University of Colorado, Denver38
- University of Aarhus35
- Chinese University of Hong Kong33
Where studies are running
- California350
- Alabama153
- Texas120
- Massachusetts118
- New York115
- Arizona106
- Florida102
- Maryland88
- Colorado85
- Illinois79
Recruiting studies6,091 total
- NCT07124676Recruiting
Comparing two systems for classifying second-degree vaginal tears after childbirth
This study looks at two different ways to classify second-degree tears that happen during a vaginal birth. The goal is to see which system better predicts problems after delivery, helping doctors provide the best care.
Naples, ItalyAges 18 years+ - NCT07118748Recruiting
Pharmacy antibiotics for cystitis with decision support tool
This trial tests a new way for women to get antibiotics for simple bladder infections (cystitis) directly from a pharmacy, without needing to see a doctor first. A computer tool helps the pharmacist make sure it is safe. This could make treatment faster and easier for you.
Aire-sur-l'AdourAges 18–65 - NCT07124702Recruiting
Quitting dual cigarette and e-cigarette use in pregnancy
This study tests a program to help pregnant people under 21 weeks who smoke both cigarettes and e-cigarettes. The goal is to help them quit both, focusing on those with lower household income.
Buffalo, New YorkAges 18 years+ - NCT07125391RecruitingPhase 2
Chemo plus propranolol before surgery for advanced ovarian cancer
This trial tests adding propranolol (a heart medication) to standard chemotherapy before surgery for advanced high-grade serous ovarian cancer. The goal is to see if this combination helps shrink tumors more effectively.
Hefei, AnhuiAges 18–75 - NCT07125885Recruiting
Pregnancy and postpartum health study
This study follows women who are planning to become pregnant, are currently pregnant, or have recently given birth. It aims to learn more about health during pregnancy and after childbirth.
Shanghai, Shanghai MunicipalityAges 18–50 - NCT07125209Recruiting
Chemotherapy and thinking for ovarian cancer
This study looks at how chemotherapy given before surgery for ovarian cancer may affect thinking and memory. It helps doctors understand the cognitive side effects of treatment so they can better support patients.
Madison, WisconsinAges 18 years+ - NCT07123909Recruiting
Immune adsorbent therapy for dialysis patients with inflammation
This study tests a therapy that absorbs inflammatory substances from the blood during dialysis. It may help people on dialysis who have ongoing inflammation, shown by high IL-6 or CRP levels.
MoscowAges 18 years+ - NCT07119996RecruitingPhase 1
Vitamin B3 to boost immunotherapy for bladder cancer
This trial tests whether taking vitamin B3 can help immunotherapy work better for people with bladder cancer. It’s for patients who have a certain type of bladder cancer and have had a recent infection that needed antibiotics.
Guangzhou, GuangdongAges 18 years+ - NCT07123090RecruitingPhase 2
Triple Therapy for Advanced Kidney Cancer
This trial tests a combination of three drugs—sasanlimab (immunotherapy), palbociclib (targeted therapy), and axitinib (VEGF inhibitor)—for people with advanced kidney cancer who have not had prior treatment. It aims to see if this triple therapy is safe and effective.
Boston, MassachusettsAges 18 years+ - NCT07121543Recruiting
Cervical cancer radiation side effect study
This study looks at how cervical cancer and radiation therapy affect the body. It aims to understand why side effects happen, which could lead to better treatment in the future.
La Jolla, CaliforniaAges 18 years+ - NCT07119177Recruiting
Long-term effects of gestational diabetes on health
This study looks at how gestational diabetes (high blood sugar during pregnancy) may affect your health over the long term. It involves reviewing your pregnancy records and doing follow-up check-ups to understand changes in your body.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07124871RecruitingPhase 2
PRP exosomes therapy for erectile dysfunction
This trial tests whether an injection of PRP exosomes can improve erectile dysfunction in men who have had some success with ED pills. It requires you to stop all other ED treatments for the study and attempt sex regularly.
ThessalonikiAges 40–70 - NCT07114029Recruiting
Mesh-free prolapse surgery study using vNOTES approach
This trial tests a new surgical method called vNOTES for repairing pelvic organ prolapse without using mesh. It aims to see if this approach improves symptoms and anatomy recovery for women with moderate to severe prolapse.
IstanbulAges 18–75 - NCT07106814RecruitingEarly Phase 1
Metabolically armed TIL therapy for advanced solid tumors
This trial tests a new cell therapy (Meta10-TIL) made from your own immune cells that were trained to attack cancer. It is for people with advanced solid tumors that have stopped responding to standard treatments, including cervical, liver, lung, breast, ovarian, head and neck, or colorectal cancer.
Hefei, AnhuiAges 19–70 - NCT07110285Recruiting
AI vs. doctor decision for IVF trigger day
This trial compares an artificial intelligence (AI) algorithm to doctors to decide the best day to give the trigger shot during IVF. It aims to see if AI can improve the number of mature eggs retrieved.
HerzliyaAges 18–45 - NCT07109986RecruitingPhase 1
Study of UB-VV410 for active lupus or lupus nephritis
This trial tests a new treatment, UB-VV410, for people with active systemic lupus erythematosus (SLE) or lupus nephritis (kidney inflammation caused by lupus) that hasn't responded to standard treatments. It aims to see if this therapy can help control the disease.
NanjingAges 18–65 - NCT07108270RecruitingPhase 2
Study of dostarlimab plus chemotherapy for advanced or recurrent endometrial cancer
This trial tests a combination of the immunotherapy drug dostarlimab with standard chemotherapy (carboplatin and paclitaxel) for people with advanced or recurrent endometrial cancer that has a specific genetic feature called dMMR or MSI-H. The goal is to see if this combination works better than chemotherapy alone.
Jinan, ShandongAges 18 years+ - NCT07112651Recruiting
New medication for hot flashes in perimenopausal women
This study tests whether a new medication (CL25216) can help reduce hot flashes and other menopause symptoms in women going through perimenopause. It is specifically for overweight women who are still having irregular periods.
VijayawadaAges 40–55 - NCT07109726RecruitingPhase 1/Phase 2
Testing TER-2013 for advanced tumors with AKT/PI3K/PTEN changes
This trial tests a new drug called TER-2013, alone or combined with another drug (fulvestrant), for people with advanced solid tumors that have specific genetic changes in the AKT/PI3K/PTEN pathway. It aims to see if the drug is safe and effective.
Duarte, CaliforniaAges 18 years+ - NCT07114601RecruitingPhase 1
Study of LY4257496 for people with GRPR-positive solid tumors
This trial tests a new drug, LY4257496, in people with certain types of cancer that have a protein called GRPR on their cells. The study aims to see if the drug can help shrink tumors or slow the cancer's growth.
Duarte, CaliforniaAges 18 years+ - NCT07106762RecruitingPhase 2/Phase 3
Study of new targeted drug vs chemo for bladder cancer
This trial tests a new drug called Izalontamab Brengitecan (a targeted therapy that delivers chemo straight to cancer cells) against standard platinum chemotherapy for people whose bladder cancer worsened after immunotherapy. It may be an option if you are fit for chemo but haven't had platinum chemo recently.
Gilbert, ArizonaAges 18 years+ - NCT07109713Recruiting
Cranberry products and women's health study
This trial tests if cranberry-based products can affect the natural balance of bacteria in the female body. It aims to understand how diet might support women's health.
Chicago, IllinoisAges 18–45 - NCT07115043RecruitingPhase 1/Phase 2
Study of AZD6750 for advanced solid tumors
This trial tests a new drug called AZD6750 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective.
Grand Rapids, MichiganAges 18 years+ - NCT05062707Recruiting
Study of early aging in young people during cancer treatment
This study looks at how “early aging” changes show up during treatment in young adults with cancer. It may help doctors better understand health effects during curative therapy and improve care for people your age.
GroningenAges 18–39
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,091 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,865 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.